DIA names Barbara Lopez Kunz global chief executive

Thursday, August 1, 2013

DIA, a neutral, global, professional member-driven association of nearly 18,000 professionals involved in the discovery, development and life cycle management of pharmaceuticals, biotechnology, medical devices and related healthcare products, has named Barbara Lopez Kunz global chief executive, to lead the organization beginning in September. Kunz brings worldwide leadership experience to DIA as former president of the global health and life sciences business at Battelle, an international science and technology nonprofit organization that explores emerging areas of science, develops and commercializes technology and manages laboratories.

[Read More]

BBK Worldwide supports “Boston Strong” at DIA

Friday, June 21, 2013

BBK is empowering attendees of DIA’s 49th annual meeting, in Boston June 23-27, to support victims of the Boston Marathon attacks. In the spirit of using “mobile for good”—and leveraging BBK’s mobile platform—meeting attendees can text “Boston Strong” to 617-706-4000 any time during the conference.

[Read More]

Icon, DIA to deliver new educational product

Monday, February 11, 2013

Icon,a global provider of outsourced development, has formed a collaboration with DIA, a neutral, global, professional, member-driven association of nearly 18,000 pharmaceutical, biotechnology, and medical device professionals, to deliver the first solution-provider webinar, which offers free access to knowledge and innovative solutions to overcome some of the key challenges in medical product development.

[Read More]

DIA names Stephen P. Spielberg editor-in-chief of TIRS journal

Friday, January 25, 2013

DIA, a neutral, global, professional and member-driven association of nearly 18,000 professionals, announced the arrival of Stephen P. Spielberg, M.D., Ph.D., as editor-in-chief of the newly launched, official DIA peer-reviewed scientific journal, Therapeutic Innovation & Regulatory Science (TIRS).

[Read More]